Saxenda (liraglutide) is a prescription-only injectable medication in the same class as Ozempic (semaglutide). However, unlike Ozempic, Saxenda is approved by the Food and Drug Administration (FDA) ...

Daphne Berryhill is an oncology pharmacist and freelance writer. She loves the collaborative process of creating health content. Her goal as a writer is to offer information that’s meaningful, ...

Saxenda (liraglutide) is a prescription drug that’s used for weight management. Saxenda’s cost may depend on factors such as whether you have health insurance and the pharmacy you use. Saxenda is used ...

On December 23, 2014, the FDA approved liraglutide, under the name Saxenda, to treat obesity, after having previously approved it under the name Victoza to treat type 2 diabetes mellitus (T2DM). As ...

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...

Saxenda (liraglutide) is a brand-name subcutaneous injection that’s prescribed for weight management. The cost of the drug with and without insurance can depend on several factors, such as whether ...

Novo Nordisk announced the launch of Saxenda (liraglutide [rDNA origin]) injection as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult ...

Saxenda is a brand-name injectable solution prescribed for long-term weight management in adults and some children. It contains the active ingredient liraglutide. Saxenda is not safe to use during ...

Please provide your email address to receive an email when new articles are posted on . Saxenda, approved to treat obesity and type 2 diabetes in Europe and the United States, may reduce the number of ...

More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...

After Novo Nordisk’s popular obesity medicine Wegovy went into short supply, people turned to the company’s first-generation weight-loss drug, Saxenda, for treatment. Now, the company is struggling to ...